The largest database of trusted experimental protocols

Anti cd45ro

Manufactured by Beckman Coulter

Anti-CD45RO is a monoclonal antibody that binds to the CD45RO antigen expressed on the surface of memory T cells. It is a laboratory reagent used for the identification and enumeration of memory T cells in flow cytometry applications.

Automatically generated - may contain errors

2 protocols using anti cd45ro

1

Immunophenotyping of T-cell Subsets

Check if the same lab product or an alternative is used in the 5 most similar protocols
Immunophenotyping was performed by flow cytometric analysis (five-colour flow cytometer FC-500; Beckman Coulter with CXP software).
For the staining of T-lymphocyte differentiation stages the following antibodies were used: R-Phycoerythrin-Cyanine 7 (PC7)-conjugated anti-CD4, anti-CD8, Phycoerythrin-Texas red X (ECD)-conjugated anti-CD8, anti-CD45RO; PC5-conjugated anti-CD27, and anti-CD25 (all from Beckman Coulter). For the staining of Tregs we used anti-CD4 PC7, anti-CD127 PE, and anti-CD25 PC5 (Beckman Coulter).
T lymphocytes, both CD4 and CD8, were divided into naïve CD45RO-CD27+, early differentiated (ED) CD45RO+CD27+, late differentiated (LD) CD45RO+CD27-, and fully differentiated effector (FD) CD45RO-CD27- memory T cells. In CD8+ cells a unique CD45RO-CD27dim intermediate population was determined as well [22 (link)] (Fig. 1). Treg cells were defined as CD4+CD25highCD127low [24 (link)] in accordance with recent studies that demonstrated that the description of Tregs as a CD4+CD25highCD127low phenotype correlates well with FoxP3 expression [25 (link), 26 (link)].
+ Open protocol
+ Expand
2

Multiparametric Flow Cytometry Phenotyping

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were harvested and phenotypically characterized by 10-color flow cytometry (Navios, Beckman Coulter) using the following antibodies: anti-CD45 (J.33), anti-CD14 (RMO52), anti-CD3 (UCHT-1), anti-CD56 (N901), anti-CD19 (J3-119), anti-CD16 (3G8), anti-CD4 (13B8.2), anti-CD8 (B9.11), anti-CD25 (B1.49.9), anti-CD314 (ON72), anti-αβ-TCR (BW242/412), anti-γδ-TCR (IMMU510), anti-CD45RO (UCHL1), anti-CD45RA (2H4) and anti-CD62L (DREG56) (Beckman Coulter; except antiαβ-TCR, Miltenyi Biotec). For the assessment of viability, 7-aminoactinomycin D (Beckman Coulter) was used, and measurements were performed using a single-platform approach. EBV-specific lymphocytes were identified by staining with various MHC-I and MHC-II antibodies using multimer technology: LMP2A (A*02:01), EBNA1 (B*35:01), EBNA3A (B*07:02 and B*08:01), BMLF1 (A*02:01; Immudex) and EBNA1 (DRB1*04:01; ProImmune).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!